Ignite Creation Date:
2025-12-24 @ 2:44 PM
Ignite Modification Date:
2025-12-27 @ 6:20 AM
Study NCT ID:
NCT00675259
Status:
COMPLETED
Last Update Posted:
2018-07-24
First Post:
2008-05-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II NCT (Neoadjuvant Chemotherapy) w/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast Cancer
Sponsor:
Ohio State University Comprehensive Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-07
Start Date Type:
None
Primary Completion Date:
2011-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-03
Completion Date Type:
ACTUAL
First Submit Date:
2008-05-08
First Submit QC Date:
None
Study First Post Date:
2008-05-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-11-10
Results First Submit QC Date:
None
Results First Post Date:
2016-08-24
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-06-26
Last Update Post Date:
2018-07-24
Last Update Post Date Type:
ACTUAL